First Prime Editing Inside the Human Body: A One-Time Fix for Wilson Disease Enters the Clinic
Prime Medicine has dosed the first patient with PM577a, an infusion designed to rewrite a single faulty DNA letter in liver cells and let the body clear excess copper again. First data are expected in 2027.